Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk.
BACKGROUND: The association between rs13387042 polymorphism on 2q35 and breast cancer (BC) has been widely evaluated since it was first identified through genome-wide association approach. However, the results have been inconclusive. To investigate this inconsistency, we performed a meta-analysis of...
Main Authors: | Chao Gu, Liang Zhou, Jianping Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3718795?pdf=render |
Similar Items
-
Estudio de asociación entre los alelos de baja penetrancia rs3803662 (TOX3), rs13387042 (2q35) y rs13281615 (8q24) y aumento del riesgo para cáncer de mama, en población chilena
by: Elematore Carrasco, Isabel Patricia
Published: (2013) -
Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.
by: Tao Huang, et al.
Published: (2013-01-01) -
The Effect of Subsequent Pregnancy on Prognosis in Young Breast Cancer Patients (≤35 Years Old) According to Hormone Receptor Status
by: Li Y, et al.
Published: (2021-02-01) -
Quantitative assessment of the association between rs2046210 at 6q25.1 and breast cancer risk.
by: Xi Wu, et al.
Published: (2013-01-01) -
Effect of leptin receptor Q223R polymorphism on breast cancer risk
by: Ghorban Mohammadzadeh, et al.
Published: (2014-08-01)